Claire Snowdon
Institute of Cancer Research(GB)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Estrogen and related hormone effects, Statistical Methods in Clinical Trials, Health Systems, Economic Evaluations, Quality of Life, Breast Cancer Treatment Studies
Most-Cited Works
- → A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer(2004)1,763 cited
- → Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen(2009)813 cited
- → Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study(2007)425 cited
- → Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial(2020)340 cited
- → Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial(2018)229 cited
- → Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer(2022)179 cited
- → Quality of Life in the Intergroup Exemestane Study: A Randomized Trial of Exemestane Versus Continued Tamoxifen After 2 to 3 Years of Tamoxifen in Postmenopausal Women With Primary Breast Cancer(2006)178 cited
- → Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial(2019)96 cited
- → First mature analysis of the Intergroup Exemestane Study(2006)65 cited
- → Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation(2012)50 cited